tenofovir has been researched along with Albuminuria in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (11.76) | 29.6817 |
| 2010's | 13 (76.47) | 24.3611 |
| 2020's | 2 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| Boesecke, C; Piduhn, H; Rockstroh, JK; Schlabe, S; Schwarze-Zander, C; Stoffel-Wagner, B; Strassburg, CP; Wasmuth, JC | 1 |
| Hadigan, CM; Hazra, R; Jones, SE; Kopp, JB; Mattingly, AS; Purdy, JB; Reynolds, JC; Unsal, AB | 1 |
| Di Nicola, M; Falasca, K; Francisci, D; Gabrielli, C; Porfilio, I; Schiaroli, E; Ucciferri, C; Vecchiet, J | 1 |
| Akpomiemie, G; Arulappan, N; Chersich, MF; Majam, M; Mashabane, N; Moorhouse, M; Venter, WDF | 1 |
| Goorhuis, A; Kooij, KW; Post, FA; Prins, M; Reiss, P; van der Valk, M; van Zoest, RA; Vogt, L; Wit, FWNM | 1 |
| Bennett, M; Coca, SG; Defechereux, P; Gandhi, M; Glidden, DV; Grant, RM; Jotwani, V; Liu, A; Mehrotra, M; Parikh, CR; Scherzer, R; Shlipak, MG | 1 |
| Agyei, NA; Cotton, M; Frigati, L; Machemedze, T; Mahtab, S; Myer, L; Nourse, P; Perrazzo, S; Ray, P; Zar, H | 1 |
| Adebisi, SA; Adedeji, NO; Adedeji, TA | 1 |
| Daar, ES; Gupta, SK; Ha, B; Kitch, D; McComsey, GA; Melbourne, K; Sax, PE; Tierney, C; Wyatt, CM | 1 |
| Almeida, JR; Esberard, EB; Lopes, PF; Lugon, JR; Medeiros, T; Mendes, GF; Patricio, JA; Silva, AA | 1 |
| Abram, ME; Arribas, JR; Avihingsanon, A; Benson, P; Bloch, M; Cheng, A; Chetchotisakd, P; Crofoot, G; Custodio, JM; Fordyce, MW; Gathe, J; Gupta, SK; Lichtenstein, K; McCallister, S; Post, FA; Pozniak, A; Ramgopal, M; SenGupta, D; Wei, X | 1 |
| Arribas, JR; Brinson, C; Brunetta, J; Callebaut, C; Cheng, A; Cheret, A; Clarke, A; Clumeck, N; Das, M; Fordyce, M; Mussini, C; Oka, S; Rashbaum, B; Sax, PE; Stephens, J; Tashima, K; Tebas, P; Wohl, D; Zhong, L | 1 |
| Bogner, JR; Hilge, R; Schrader, S; Seybold, U; Zeder, AJ | 1 |
| Chetty, K; Connolly, JO; Edwards, SG; Hall, AM; Lapsley, M; O'Farrell, S; Unwin, RJ; Williams, IG | 1 |
| Agarwal, R; Dubé, MP; Gupta, SK; Mather, KJ; Shen, C | 1 |
| Ando, M; Nitta, K; Tsuchiya, K | 1 |
| Bower, M; Gazzard, B; Jones, R; Mandalia, S; Moyle, G; Nelson, M; Stebbing, J | 1 |
1 review(s) available for tenofovir and Albuminuria
| Article | Year |
|---|---|
How to manage HIV-infected patients with chronic kidney disease in the HAART era.
Topics: Adenine; Albuminuria; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Black People; Cystatin C; Glomerular Filtration Rate; HIV Infections; Humans; Kidney Failure, Chronic; Organophosphonates; Prevalence; Proteinuria; Risk Factors; Tenofovir; Viral Load | 2012 |
5 trial(s) available for tenofovir and Albuminuria
| Article | Year |
|---|---|
Is laboratory screening prior to antiretroviral treatment useful in Johannesburg, South Africa? Baseline findings of a clinical trial.
Topics: Adult; Albuminuria; Anemia; Anti-HIV Agents; Antigens; CD4 Lymphocyte Count; Cities; Clinical Laboratory Techniques; Coinfection; Cost-Benefit Analysis; Creatinine; Female; Health Care Costs; Hemoglobins; Hepatitis B; HIV Infections; Humans; Kidney Diseases; Male; Mass Screening; Neutropenia; South Africa; Tenofovir; Transaminases | 2017 |
Pre-exposure Prophylaxis With Tenofovir Disoproxil Fumarate/Emtricitabine and Kidney Tubular Dysfunction in HIV-Uninfected Individuals.
Topics: Adult; Albuminuria; Alpha-Globulins; Anti-HIV Agents; Biomarkers; Cross-Sectional Studies; Emtricitabine; Female; Glomerular Filtration Rate; HIV; HIV Infections; Humans; Kidney Diseases; Kidney Function Tests; Male; Pre-Exposure Prophylaxis; Proteinuria; Tenofovir; Transgender Persons; Urine; Young Adult | 2018 |
Changes in proteinuria and albuminuria with initiation of antiretroviral therapy: data from a randomized trial comparing tenofovir disoproxil fumarate/emtricitabine versus abacavir/lamivudine.
Topics: Adenine; Adult; Albuminuria; Anti-HIV Agents; Deoxycytidine; Dideoxynucleosides; Drug Combinations; Emtricitabine; Female; HIV Infections; HIV-1; Humans; Lamivudine; Linear Models; Male; Organophosphonates; Proteinuria; Tenofovir | 2014 |
Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Patients With Renal Impairment: 48-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study.
Topics: Adult; Albuminuria; Bone Density; Cobicistat; Drug Substitution; Drug Therapy, Combination; Emtricitabine; Female; Glomerular Filtration Rate; HIV Infections; Humans; Male; Middle Aged; Proteinuria; Quinolones; Renal Insufficiency; Tenofovir | 2016 |
Brief Report: A Randomized, Double-Blind Comparison of Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate, Each Coformulated With Elvitegravir, Cobicistat, and Emtricitabine for Initial HIV-1 Treatment: Week 96 Results.
Topics: Adenine; Alanine; Albuminuria; Anti-HIV Agents; Bone Density; CD4 Lymphocyte Count; Cobicistat; Double-Blind Method; Drug Combinations; Emtricitabine; Female; HIV Infections; HIV-1; Humans; Male; Proteinuria; Quinolones; RNA, Viral; Tenofovir | 2016 |
11 other study(ies) available for tenofovir and Albuminuria
| Article | Year |
|---|---|
Switching tenofovir disoproxil fumarate to tenofovir alafenamide in a real life setting: what are the implications?
Topics: Age Factors; Alanine; Albuminuria; Cholesterol, LDL; Drug Substitution; Female; HIV Infections; Humans; Male; Middle Aged; Proteinuria; Retrospective Studies; Tenofovir; Time Factors | 2020 |
Effect of Antiretroviral Therapy on Bone and Renal Health in Young Adults Infected With HIV in Early Life.
Topics: Absorptiometry, Photon; Acid-Base Equilibrium; Adult; Age of Onset; Albuminuria; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Bone Density; Bone Diseases, Metabolic; Bone Remodeling; Case-Control Studies; Creatinine; Cross-Sectional Studies; Didanosine; Female; Glomerular Filtration Rate; HIV Infections; Humans; Kidney Function Tests; Longitudinal Studies; Male; Osteocalcin; Prospective Studies; Proteinuria; Renal Insufficiency; Risk Factors; Stavudine; Tenofovir; Time Factors; Young Adult | 2017 |
Predictive factors and prevalence of microalbuminuria in HIV-infected patients: a cross-sectional analysis.
Topics: Adult; Albuminuria; Cross-Sectional Studies; Female; HIV Infections; Humans; Male; Middle Aged; Predictive Value of Tests; Prevalence; Prospective Studies; Reverse Transcriptase Inhibitors; Risk Factors; Tenofovir | 2017 |
Higher Prevalence and Faster Progression of Chronic Kidney Disease in Human Immunodeficiency Virus-Infected Middle-Aged Individuals Compared With Human Immunodeficiency Virus-Uninfected Controls.
Topics: Albuminuria; Anti-HIV Agents; Case-Control Studies; Disease Progression; Female; Follow-Up Studies; Glomerular Filtration Rate; HIV Infections; Humans; Logistic Models; Longitudinal Studies; Male; Middle Aged; Multivariate Analysis; Phosphates; Prevalence; Prospective Studies; Renal Insufficiency, Chronic; Risk Factors; Tenofovir | 2017 |
Prevalence of risk factors for chronic kidney disease in South African youth with perinatally acquired HIV.
Topics: Adolescent; Africa South of the Sahara; Albuminuria; Anti-Retroviral Agents; CD4 Lymphocyte Count; Child; Comorbidity; Female; Glomerular Filtration Rate; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Male; Prevalence; Renal Insufficiency, Chronic; Risk Factors; Tenofovir; Viral Load | 2019 |
Effects of Highly Active Antiretroviral Therapy on Albuminuria in HIVinfected Persons.
Topics: Adolescent; Adult; Age Factors; Albuminuria; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Drug Combinations; Drug Therapy, Combination; Female; Glomerular Filtration Rate; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Prospective Studies; Sex Factors; Tenofovir; Young Adult; Zidovudine | 2020 |
Tenofovir monotherapy for hepatitis B after 1 year does not produce renal dysfunction, but is associated with hyperparathyroidism not related to vitamin D.
Topics: Adult; Albuminuria; Alkaline Phosphatase; Antiviral Agents; beta 2-Microglobulin; Creatinine; Cystatin C; Electrolytes; Female; Glomerular Filtration Rate; Hepatitis B; Humans; Hyperparathyroidism; Male; Middle Aged; Parathyroid Hormone; Renal Insufficiency; Serum Albumin; Tenofovir; Urea; Uric Acid; Vitamin D | 2016 |
Medium-grade tubular proteinuria is common in HIV-positive patients and specifically associated with exposure to tenofovir disoproxil Fumarate.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albuminuria; Anti-HIV Agents; Cross-Sectional Studies; Female; Germany; HIV; HIV Infections; Humans; Male; Middle Aged; Prevalence; Proteinuria; Risk Factors; Tenofovir; Young Adult | 2016 |
Subclinical tubular injury in HIV-infected individuals on antiretroviral therapy: a cross-sectional analysis.
Topics: Acetylglucosaminidase; Adenine; Adult; Aged; Albuminuria; Anti-Retroviral Agents; Creatinine; Cross-Sectional Studies; Disease Progression; Female; Glomerular Filtration Rate; HIV Infections; Humans; Kidney Tubules, Proximal; Male; Middle Aged; Organophosphonates; Phosphates; Proteinuria; Retinol-Binding Proteins; Risk Factors; Sensitivity and Specificity; Tenofovir | 2009 |
Neither proteinuria nor albuminuria is associated with endothelial dysfunction in HIV-infected patients without diabetes or hypertension.
Topics: Adenine; Adult; Albuminuria; Alkynes; Anti-HIV Agents; Benzoxazines; Brachial Artery; Chi-Square Distribution; Creatinine; Cyclopropanes; Dideoxynucleosides; Endothelium, Vascular; Female; Glomerular Filtration Rate; HIV Infections; Humans; Linear Models; Male; Middle Aged; Organophosphonates; Proteinuria; Tenofovir; Ultrasonography; Vasodilation | 2011 |
Renal dysfunction with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy regimens is not observed more frequently: a cohort and case-control study.
Topics: Adenine; Albuminuria; Antiretroviral Therapy, Highly Active; Case-Control Studies; Cohort Studies; Creatinine; Follow-Up Studies; HIV Infections; Humans; Organophosphonates; Proteinuria; Renal Insufficiency; Tenofovir | 2004 |